The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study
Launched by WOMAN'S HEALTH UNIVERSITY HOSPITAL, EGYPT · Feb 15, 2023
Trial Information
Current as of July 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how common Polycystic Ovary Syndrome (PCOS) is among young women who show signs of hyperandrogenism, which means they may experience symptoms like acne, excessive hair growth, or hair loss. Researchers will use updated guidelines to help diagnose PCOS in participants, aiming to understand better how this condition affects young reproductive females.
To join the study, participants must be between the ages of 15 and 35 and have symptoms of hyperandrogenism. The trial is currently recruiting participants, and those who qualify can expect to undergo assessments to determine if they have PCOS based on the latest clinical standards. This research is important as it may help identify more young women with PCOS and improve their treatment and management options.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Clinical hyperandrogenism
- Exclusion Criteria:
- • Age less than 15 or more than 35 years.
About Woman's Health University Hospital, Egypt
Women's Health University Hospital in Egypt is a leading institution dedicated to advancing women's health through innovative clinical research and comprehensive patient care. As a prominent clinical trial sponsor, the hospital focuses on a wide range of health issues affecting women, including reproductive health, maternal care, and gynecological conditions. With a commitment to scientific excellence and ethical standards, the hospital collaborates with renowned researchers and healthcare professionals to deliver impactful studies that enhance treatment options and improve health outcomes for women. Through its robust infrastructure and multidisciplinary approach, Women's Health University Hospital aims to contribute significantly to the global body of knowledge in women's health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Doha, , Qatar
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials